Advertisement
Opthea Limited

Opthea Limited Fundamental Analysis

OPTNASDAQ
HealthcareBiotechnology
$3.41
$0.05(1.49%)
U.S. Market opens in 16h 3m
Advertisement

Opthea Limited Fundamental Analysis

Opthea Limited (OPT) shows weak financial fundamentals with a PE ratio of -3.20, profit margin of -1121.75%, and ROE of 1.09%. The company generates $0.0B in annual revenue with weak year-over-year growth of -22.65%.

Key Strengths

PEG Ratio-0.06

Areas of Concern

ROE1.09%
Operating Margin-1072.40%
Current Ratio0.14
We analyze OPT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -84102.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-84102.3/100

We analyze OPT's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPT struggles to generate sufficient returns from assets.

ROA > 10%
-4.40%

Valuation Score

Excellent

OPT trades at attractive valuation levels.

PE < 25
-3.20
PEG Ratio < 2
-0.06

Growth Score

Moderate

OPT shows steady but slowing expansion.

Revenue Growth > 5%
-22.65%
EPS Growth > 10%
22.22%

Financial Health Score

Moderate

OPT shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.14

Profitability Score

Weak

OPT struggles to sustain strong margins.

ROE > 15%
109.04%
Net Margin ≥ 15%
-1121.75%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT Expensive or Cheap?

P/E Ratio

OPT trades at -3.20 times earnings. This suggests potential undervaluation.

-3.20

PEG Ratio

When adjusting for growth, OPT's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Opthea Limited at -3.98 times its book value. This may indicate undervaluation.

-3.98

EV/EBITDA

Enterprise value stands at -22.12 times EBITDA. This is generally considered low.

-22.12

How Well Does OPT Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-1121.75 as profit after all expenses.

-1121.75%

Operating Margin

Core operations generate -1072.40 in profit for every $100 in revenue, before interest and taxes.

-1072.40%

ROE

Management delivers $1.09 in profit for every $100 of shareholder equity.

1.09%

ROA

Opthea Limited generates $-4.40 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.40%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates limited operating cash flow of $-789.94M, signaling weaker underlying cash strength.

$-789.94M

Free Cash Flow

Opthea Limited generates weak or negative free cash flow of $-971.47M, restricting financial flexibility.

$-971.47M

FCF Per Share

Each share generates $-0.78 in free cash annually.

$-0.78

FCF Yield

OPT converts -2.84% of its market value into free cash.

-2.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

-3.98

vs 25 benchmark

P/S Ratio

Price to sales ratio

29007.97

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.09

vs 25 benchmark

ROA

Return on assets percentage

-4.40

vs 25 benchmark

ROCE

Return on capital employed

0.71

vs 25 benchmark

How OPT Stacks Against Its Sector Peers

MetricOPT ValueSector AveragePerformance
P/E Ratio-3.2029.01 Better (Cheaper)
ROE109.04%730.00% Weak
Net Margin-112175.29%-53564.00% (disorted) Weak
Debt/Equity-1.230.39 Strong (Low Leverage)
Current Ratio0.144.47 Weak Liquidity
ROA-440.15%-18932.00% (disorted) Weak

OPT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-59.58%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-284.20%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-142.85%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ